Dr Devan Mahadavan

DevanOurCardiologists

Director & Cardiologist Western HeartCare

BMBS FRACP FCSANZ PHD FESC

Dr Devan Mahadavan is an imaging cardiologist with a clinical and research interest in heart failure, valvular heart disease, rare cardiomyopathies and inflammatory heart disease as well as pulmonary hypertension. He specialises in all forms of cardiac imaging and is active in developing advanced imaging technologies.

Dr Devan Mahadavan graduated in 1997 from Flinders University. He subsequently completed his clinical cardiology training at the Queen Elizabeth Hospital in 2005 and then spent three years in the United Kingdom and Brisbane completing his post-graduate and fellowship training in cardiac imaging which includes all forms of echocardiography, cardiac MRI and cardiac CT. He has level 3 accreditation for both echocardiography and cardiac MRI and level A accreditation for Cardiac CT.

Since 2009, he has been working as a Staff Specialist Cardiologist and also heading cardiac imaging at the Queen Elizabeth Hospital/Lyell McEwin Hospital. He also works at the new Royal Adelaide Hospital as an imaging Cardiologist. In 2015, he was accepted as a Fellow of the European Society of Cardiology.

His research interests are predominantly in heart failure with preserved ejection fraction, the focus of his doctoral thesis. He also has a strong interest in valvular heart disease with publications in peer -reviewed journals, as well as being an invited speaker in national and international meetings in his areas of interest. His major focus is to implement advanced imaging technologies into his daily practice, as well as provide dedicated individualised care for his patients.

Published manuscripts

Burnet S. Mahadevan G. Lee A. Rischmueller M. Sacral insufficiency fracture–a case of post-coital back pain. Rheumatology. 2001 Sep; 40(9): 1065-6.
Mahadevan G, Thorne SA , Steeds RP “ Echocardiography in Cryptogenic Cerebrospinal Abscess” J Am Soc Echocardiography. 2008 Apr; 21(4): 401-3.
Mahadevan G, Davis RC, Frenneaux MP , Hobbs FDR, Lip GYH, Sanderson JE , Davies MK “Viewpoint: Left ventricular ejection fraction – are the revised cut-offs for defining systolic dysfunction sufficiently evidenced based?” Heart. 2008 Apr; 94(4): 426-8 (Review).
T T Phan, K Abozguia, G Nallur Shivu, M Gnanadevan, I Ahmed, L Williams, M Frenneaux. “Left ventricular torsion and strain patterns in heart failure with normal ejection fraction are similar to age-related changes” European Journal of Echo Advance Access.
T T Phan, K Abozguia, G Nallur Shivu, G Mahadevan, I Ahmed, L Williams, M Frenneaux “Heart Failure with Preserved Ejection Fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle”. J Am Coll Cardiol. 2009 Jul 28; 54(5):402-9.
Neil C, Nguyen TH, Kucia A, Crouch B, Sverdlov A, Chirkov Y, Mahadavan G, Selvanayagam J, Dawson D, Beltrame J, Zeitz C, Unger S, Redpath T, Frenneaux M, Horowitz J. Slowly resolving global myocardial inflammation/oedema in Tako-Tsubo cardiomyopathy: evidence from T2-weighted cardiac MRI. Heart. 2012 Sep; 98(17): 1278-84
Nguyen TH, Neil CJ, Sverdlov AL, Mahadavan G, Chirkov YY, Kucia AM, Stansborough J, Beltrame JF, Selvanayagam JB, Zeitz CJ, Struthers AD, Frenneaux MP, Horowitz JD. N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy. Am J Cardiol. 2011 Nov 1;108(9):1316-21.
Carrington MJ, Ball J, Horowitz JD, Marwick TH, Mahadevan G, Wong C, Abhayaratna WP, Haluska B, Thompson DR, Scuffham PA, Stewart S. Navigating the fine line between benefit and risk in chronic atrial fibrillation: Rationale and design of the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY). Int J Cardiol. 2011 Nov 11.
Mahadevan G, DwivediG, WilliamsL,SteedsRP, Frenneaux M. Epidemiology and diagnosis of heart failure with preserved left ventricular ejection fraction: rationale and design of the study. Eur J Heart Fail. 2012 Jan;14(1):106-12.
Brain natriuretic peptide: a biomarker for all cardiac disease? Mahadavan G, Nguyen TH, Horowitz JD. Curr Opin Cardiol. 2014 Mar;29(2):160-6.
Reference values for mitral and tricuspid annular dimensions using two-dimensional echocardiography. Dwivedi G, Mahadevan G, Jimenez D, Frenneaux M, Steeds RP. Echo Res Pract. 2014 Dec 1;1(2):43-50.
Stewart S, Ball J, Horowitz JD, Marwick TH, Mahadevan G, Wong C, Abhayaratna WP, Chan YK, Esterman A, Thompson DR, Scuffham PA, Carrington MJ. Lancet. 2015 Feb 28;385(9970):775-84.
Troponin-positive chest pain with unobstructed coronary arteries: incremental diagnostic value of cardiovascular magnetic resonance imaging. Pathik B, Raman B, Mohd Amin NH, Mahadavan D, Rajendran S, McGavigan AD, Grover S, Smith E, Mazhar J, Bridgman C, Ganesan AN, Selvanayagam JB. Eur Heart J Cardiovasc Imaging. 2015 Nov 20.
Platelet Reactivity Is Independent of Left Atrial Wall Deformation in Patients with Atrial Fibrillation. Procter N, Goh V, Mahadevan G, Stewart S, Horowitz J. Mediators Inflamm. 2016;. Epub 2016 Mar 16.
Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-acetylcysteine in Acute Myocardial Infarction]). Pasupathy S, Tavella R, Grover S, Raman B, Procter NEK, Du YT, Mahadavan G, Stafford I, Heresztyn T, Holmes A, Zeitz C, Arstall M, Selvanayagam J, Horowitz JD, Beltrame JF. Circulation. 2017 Sep 5;136(10):894-903. doi: 10.1161/CIRCULATIONAHA.117.027575. Epub 2017 Jun 20.